Skip to main content
Michal Mrug, MD, Nephrology, Birmingham, AL, Birmingham Veterans Affairs Medical Center

MichalMrugMD

Nephrology Birmingham, AL

Professor, Medicine, University of Alabama School of Medicine

Dr. Mrug is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mrug's full profile

Already have an account?

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Nephrology, 2002 - 2004
  • USA Health
    USA HealthResidency, Internal Medicine, 1999 - 2002
  • Karlovy University FOM
    Karlovy University FOMClass of 1995

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2002 - 2022
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

Journal Articles

  • A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan  
    Ronald D Perrone, Anjay Rastogi, Terry Watnick, Arlene B Chapman, Michal Mrug, Vicente E Torres, Fouad T Chebib, Neera K Dahl, Peter C Harris, Journal of the American Society of Nephrology

Authored Content

  • Baseline Total Kidney Volume and the Rate of Kidney Growth Are Associated with Chronic Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseDecember 2017

Press Mentions

  • Otsuka’s JYNARQUE™ (Tolvaptan) Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Otsuka’s JYNARQUE™ (Tolvaptan) Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)April 24th, 2018

Hospital Affiliations